Your institution may have access to this item. Find your institution then sign in to continue.
Title
Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C.
Authors
Rueth, Natasha M; Murray, Sara E; Huddleston, Stephen J; Abbott, Andrea M; Greeno, Edward W; Kirstein, Mark N; Tuttle, Todd M
Abstract
Oxaliplatin (OX) is increasingly used for hyperthermic intraperitoneal chemotherapy (HIPC) for patients with peritoneal metastases. Our aim was to review electrolyte disturbances and complications after HIPC with oxaliplatin (OX) versus mitomycin C (MMC).
Publication
Annals of surgical oncology, 2011, Vol 18, Issue 1, p174